Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01857752
Recruitment Status : Terminated (accrual)
First Posted : May 20, 2013
Last Update Posted : January 30, 2017
Sponsor:
Information provided by (Responsible Party):
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015